Pages that link to "Q79871435"
Jump to navigation
Jump to search
The following pages link to Effect of posttranslational modifications on the thermal stability of a recombinant monoclonal antibody (Q79871435):
Displaying 28 items.
- In vitro and in vivo modifications of recombinant and human IgG antibodies (Q26859713) (← links)
- Characterization of IgG1 conformation and conformational dynamics by hydrogen/deuterium exchange mass spectrometry (Q27654019) (← links)
- Chemical and Structural Analysis of an Antibody Folding Intermediate Trapped during Glycan Biosynthesis (Q27673777) (← links)
- A dual-mode surface display system for the maturation and production of monoclonal antibodies in glyco-engineered Pichia pastoris (Q28534600) (← links)
- FTIR markers of methionine oxidation for early detection of oxidized protein therapeutics (Q30398538) (← links)
- High-throughput biophysical analysis and data visualization of conformational stability of an IgG1 monoclonal antibody after deglycosylation (Q30675226) (← links)
- Glycosylation of therapeutic proteins: an effective strategy to optimize efficacy (Q33586660) (← links)
- Bypassing glycosylation: engineering aglycosylated full-length IgG antibodies for human therapy (Q34172070) (← links)
- Characterization of N-Linked Glycosylation in a Monoclonal Antibody Produced in NS0 Cells Using Capillary Electrophoresis with Laser-Induced Fluorescence Detection (Q35052763) (← links)
- Sialic acid methylation refines capillary electrophoresis laser-induced fluorescence analyses of immunoglobulin G N-glycans of ovarian cancer patients (Q35165824) (← links)
- Comprehensive N-Glycan Profiling of Cetuximab Biosimilar Candidate by NP-HPLC and MALDI-MS. (Q36245448) (← links)
- Chromatographic analysis of the acidic and basic species of recombinant monoclonal antibodies (Q36402682) (← links)
- Effects of glycosylation on the stability of protein pharmaceuticals (Q37114305) (← links)
- In-depth structural characterization of Kadcyla® (ado-trastuzumab emtansine) and its biosimilar candidate (Q37327321) (← links)
- Structure and function of immunoglobulins (Q37696721) (← links)
- With or without sugar? (A)glycosylation of therapeutic antibodies (Q38055447) (← links)
- Biological Characterization of a Stable Effector Functionless (SEFL) Monoclonal Antibody Scaffold in Vitro (Q38725387) (← links)
- Charge heterogeneity: Basic antibody charge variants with increased binding to Fc receptors (Q39454978) (← links)
- Physical instability of a therapeutic Fc fusion protein: domain contributions to conformational and colloidal stability (Q39535352) (← links)
- Correlating the Impact of Well-Defined Oligosaccharide Structures on Physical Stability Profiles of IgG1-Fc Glycoforms (Q40002974) (← links)
- Advanced analyses of kinetic stabilities of iggs modified by mutations and glycosylation (Q41366211) (← links)
- Development of a stable low-dose aglycosylated antibody formulation to minimize protein loss during intravenous administration (Q42287395) (← links)
- Methods to Determine the Level of Afucosylation in Recombinant Monoclonal Antibodies (Q42831562) (← links)
- Fragmentation of a recombinant monoclonal antibody at various pH. (Q46600646) (← links)
- Analytical comparability study of recombinant monoclonal antibody therapeutics. (Q52669512) (← links)
- Macro- and Micro-Heterogeneity of Natural and Recombinant IgG Antibodies (Q90211865) (← links)
- Identification of IgG1 Aggregation Initiation Region by Hydrogen Deuterium Mass Spectrometry (Q92240719) (← links)
- Effects of terminal galactose residues in mannose α1-6 arm of Fc-glycan on the effector functions of therapeutic monoclonal antibodies (Q93124298) (← links)